Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Christopher T. Cummings, Rachel M.A. Linger, Rebecca A. Cohen, Susan Sather, Gregory D. Kirkpatrick, Kurtis D. Davies, Deborah DeRyckere, H. Shelton Earp, Douglas K. Graham
Published Jun 26, 2014 · Vol. 5, No. 21 · pp. 10434-10445
De-Shen Wang, Atish Patel, Suneet Shukla, Yun-Kai Zhang, Yi-Jun Wang, Rishil J. Kathawala, Robert W. Robey, Li Zhang, Dong-Hua Yang, Tanaji T. Talele, Susan E. Bates, Suresh V. Ambudkar, Rui-Hua Xu, Zhe-Sheng Chen
Published Jun 13, 2014 · Vol. 5, No. 12 · pp. 4529-4542
Sylvia Müller, Yuan Chen, Torsten Ginter, Claudia Schäfer, Marc Buchwald, M. Lienhard Schmitz, Jana Klitzsch, Alexander Schütz, Andrea Haitel, Katharina Schmid, Richard Moriggl, Lukas Kenner, Karlheinz Friedrich, Claude Haan, Iver Petersen, Thorsten Heinzel, Oliver H. Krämer
Published Apr 12, 2014 · Vol. 5, No. 10 · pp. 3184-3196
Shigeru Kawabata, Chun-Te Chiang, Junji Tsurutani, Hideaki Shiga, Matthew L. Arwood, Takefumi Komiya, Joell J. Gills, Regan M. Memmott, Phillip A. Dennis
Published Feb 16, 2014 · Vol. 5, No. 4 · pp. 1062-1070
Keywords: Rapamycin, Pemetrexed, Drug synergy, mTOR, Thymidylate Synthase, Lung Cancer